Carbon Dioxide
NDC Package 12213-005-53

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Carbon Dioxide is a . Marketed by Nexair, Llc, this product is identified by NDC 12213-005 and is authorized under FDA application NDA206025.

Identification & Billing

NDC Package Code
12213-005-53
Package Description
1238 L in 1 CYLINDER
Product Code
11-Digit Billing Format
12213000553

Clinical Specifications

Proprietary Name
Carbon Dioxide
Dosage Form
-

Regulatory & Marketing

Labeler Name
Nexair, Llc
FDA Application #
NDA206025
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
06-01-1996
End Marketing Date
10-01-2020
Listing Expiration
10-01-2020
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (12213-005). Click a package code to view its specific billing and regulatory data.

566 L in 1 CYLINDER
12385 L in 1 CYLINDER
990 L in 1 CYLINDER
24750 L in 1 CYLINDER
1584 L in 1 CYLINDER

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 12213-005-53 identifies a specific commercial package of 1238 l in 1 cylinder of Carbon Dioxide, labeled by Nexair, Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Nexair, Llc on June 01, 1996. The current certification is valid through October 01, 2020.

How is this Nexair, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 12213000553. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
12213-005-53
11-Digit CMS (5-4-2)
12213-0005-53

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.